A digital twin (DT)-based insulin dosage simulator with an individual’s metabolic system is proposed for personalized diabetes management and decision support for clinicians and shows improved glucose prediction accuracy, enhanced detection of hypoglycemia risk, and optimized insulin dosing strategies compared with traditional approaches.
Abstract
Background/Objectives: Diabetes mellitus is a chronic metabolic disorder characterized by impaired regulation of blood glucose due to defects in insulin secretion, insulin action, or both. Physiological and lifestyle factors vary among individuals. General medicine is not applicable to all patients. In this scenario, personalized medicine for each individual becomes costly. Effective management of continuous glucose levels with accurate insulin dosage is challenging. To overcome this, a digital twin (DT)-based insulin dosage simulator with an individual’s metabolic system is proposed in this work. Methods: Various machine learning techniques, mathematical models of physiology, and risk assessment using probability are used to predict the dynamics of patient-specific glucose–insulin. Parameters such as carbohydrate intake, sleep patterns, medications, and physical activity were incorporated into this model to capture real-world variations in daily life. For glucose–insulin interactions, the Bergman Minimal Model (BMM) is used; for time-of-day variability, a circadian insulin sensitivity model is used; and for predicting metabolic risks, Bayesian risk estimation (BRE) is used, which includes hyperglycemia risk. To enhance transparency and interpret model predictions, explainable artificial intelligence (XAI) methods are employed. Results: The simulation results showed improved glucose prediction accuracy, enhanced detection of hypoglycemia risk, and optimized insulin dosing strategies compared with traditional approaches. Conclusions: Overall, the proposed digital twin model offers a scalable solution using the latest techniques A “Prescriptive Analytical Framework” is provided using the BMM and BRE for personalized diabetes management and decision support for clinicians.
Type 1 diabetes mellitus is one of the most complex chronic metabolic disorders, significantly impacting both patients' quality of life and global healthcare systems. The condition is characterized by the autoimmune destruction of pancreatic β-cells, rendering the body unable to synthesize endogenous insulin. Consequen...
D. Arotaritei, Ilea Mihail-ovidiu· World Wide Journal of Multid...· 0 citations
Type-I Diabetes Mellitus (TIDM) is characterized by
autoimmune destruction of pancreatic β-cells, resulting in absolute insulin deficiency and
impaired glucose regulation. Maintaining normoglycemia is challenging due to the nonlinear and
time-varying nature of Glucose–Insulin (GI) dynamics, meal disturbances, and p...
A. Patra, Smitta Ranjan Dutta, Anuja Nanda· Current Science, Engineering...· 0 citations
Type 2 diabetes mellitus is a heterogeneous metabolic disorder in which patients exhibit substantial inter-individual variation in therapeutic response. Although multiple pharmacological classes are available, treatment selection is frequently guided by population-level evidence and sequential therapeutic adjustment, w...
S. Rahul, Bolimera Kiran Kumar, Priya Govindarajan et al.· International journal of com...· 0 citations
Abstract Background Type 1 diabetes is characterized by absolute insulin deficiency, requiring exogenous insulin therapy to maintain blood glucose levels within safe ranges. Postprandial glucose control remains particularly challenging, and current meal-related strategies are mainly based on carbohydrate intake. Howeve...
Carlos Gallardo-García, M. E. Hernando, David Subías et al.· JMIR AI· 0 citations
Patients with diabetes in the ICU typically rely on two methods to monitor their blood glucose levels: blood tests analyzed in the laboratory and fingerstick tests. While fingerstick tests offer a cost-effective and convenient approach, they sacrifice accuracy, providing only approximate measurements. In this paper, we...
A. Popoola, Pooyan Kazemian, K. Paynabar· IISE Annual Conference &...· 0 citations
The efficacy of incorporating artificial intelligence technologies into personalized recommendations for health improvement and symptom reduction in chronic diseases has been proven, with results demonstrating significant enhancements in patients' metabolic parameters and life quality.
Z. Burova, Maksym Hudzenko, Y. Kryzhova et al.· Human and nation s health· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.